New Standard for Unresectable Hepatocellular Carcinoma?

(MedPage Today) -- SAN FRANCISCO -- After more than 20 years of trying, systemic therapy for unresectable liver cancer has improved outcomes with transarterial chemoembolization (TACE), a randomized trial showed. Patients who received durvalumab...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news